Response to comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508
Diabetes Care
.
2014 Nov;37(11):e247.
doi: 10.2337/dc14-1790.
Authors
Philip Home
1
,
Matthew Riddle
2
,
William T Cefalu
3
,
Clifford J Bailey
4
,
Reinhard G Bretzel
5
,
Stefano Del Prato
6
,
Derek Leroith
7
,
Guntram Schernthaner
8
,
Luc van Gaal
9
,
Itamar Raz
10
Affiliations
1
Newcastle University, Newcastle upon Tyne, U.K.
2
Oregon Health & Science University, Portland, OR.
3
Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA william.cefalu@pbrc.edu.
4
Aston University, Birmingham, U.K.
5
Justus Liebeg University, Giessen, Germany.
6
Department of Clinical and Experimental Medicine, University of Pisa School of Medicine, Pisa, Italy.
7
Mount Sinai Medical School, New York, NY Rambam Technion Hospital, Haifa, Israel.
8
Department of Medicine I, Rudolfstiftung Hospital, Vienna, Austria.
9
Antwerp University Hospital, Antwerp, Belgium.
10
Diabetes Unit, Department of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel.
PMID:
25342843
PMCID:
PMC5131861
DOI:
10.2337/dc14-1790
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose / metabolism*
Diabetes Mellitus, Type 2 / drug therapy*
Humans
Hypoglycemic Agents / therapeutic use*
Insulin / therapeutic use*
Substances
Blood Glucose
Hypoglycemic Agents
Insulin